XYNTHA: Effective Treatment for Hemophilia A
XYNTHA is a recombinant antihemophilic factor designed to treat bleeding episodes in adults and children with hemophilia A. It is used for on-demand treatment, perioperative management, and routine prophylaxis to reduce the frequency of bleeding episodes. This medication is not indicated for patients with von Willebrand’s disease.
Key Features:
- Indication: XYNTHA is specifically formulated for individuals with hemophilia A to manage and prevent bleeding episodes.
- Administration: It is administered intravenously after reconstitution with a provided diluent.
- Dosage: The required dose is calculated based on body weight and desired factor VIII rise, ensuring effective treatment.
- Preparation: The product comes in various dosages (250, 500, 1000, and 2000 IU) and is available in both vial and prefilled dual-chamber syringe formats.
- Safety: The purification process includes steps like affinity chromatography and solvent-detergent viral inactivation to ensure safety and efficacy.
Usage Instructions:
1. **Reconstitution:** Reconstitute the lyophilized powder with the provided diluent by slowly depressing the plunger rod into the vial.
2. **Inspection:** Visually inspect the solution for particulate matter before administration. The final solution should be clear to slightly opalescent and colorless.
3. **Administration:** Invert the vial and slowly draw the solution into a syringe. Detach the syringe from the vial adapter and discard the empty vial.
Storage and Handling:
- Store the reconstituted solution at room temperature..
- Use the solution within 3 hours after reconstitution..
- Avoid touching the rubber stopper or allowing it to touch any surface during preparation..
**Manufacturer:** Wyeth Pharmaceuticals, LLC, a subsidiary of Pfizer.
By using XYNTHA, individuals with hemophilia A can effectively manage their condition and reduce the frequency of bleeding episodes. This medication is a reliable choice for those seeking a safe and effective treatment option.
Reviews
There are no reviews yet.